INTRODUCTION
Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid (SMECE) is a rare disease first described by Chan et al in 1991. 1 It is characterised histologically by strands and nests of squamous tumour cells with nuclear polymorphism. Eosinophil infiltration is present in all cases. Immunohistologically the tumour cells are positive for cytokeratin and negative for thyroglobulin, and calcitonin. The tumours occur largely in females of middle age (32-73) and all have a history of Hashimoto's thyroiditis. 2 The tumour has up, until recently, been considered a low-grade malignancy however emerging evidence now suggests it is more aggressive.
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CASE REPORT
A 44 year old Caucasian female presented with a 4 month history of a painless enlarging mass in the left side of the neck, recent difficulty breathing on exertion, and hoarse voice. She had a 20 year history of hypothyroidism, controlled with 200mcg Thyroxine daily. Examination revealed a diffusely enlarged, hard, thyroid gland adherent to the larynx and trachea. Palpation of her neck revealed a right 3cm level II lymph node and left 1.5cm level III lymph node. Flexible nasendoscopy showed a narrowed subglottis. Vocal cord movement was symmetrical. A fine needle aspiration (FNA) of the thyroid and right level III lymph node was consistent with adenocarcinoma. A CT scan of the chest and neck demonstrated a diffusely enlarged thyroid gland, the left lobe was asymmetrically enlarged, wrapping around the trachea to contact the oesophagus. The left tracheal wall was contiguous with the thyroid, with tracheal invasion suspected. A 21x21mm right level II node and 14x18mm left level III node were identified.
The patient proceeded to operative intervention. A tracheoscopy performed at the beginning of the procedure revealed invasion of tumour bilaterally into the trachea. An extended total thyroidectomy, tracheal resection with reconstruction, and bilateral cervical neck dissections of levels II, III, IV and VI was performed. At operation, the tumour was close to, but not involving the right cricothyroid joint. The right recurrent laryngeal nerve was thickened, however was functioning on nerve stimulation. 3cm proximal to the cricothyroid joint, the left recurrent laryngeal nerve was surrounded in tumour and was sacrificed. The tumour was closely adherent to the cricoid cartilage and was partially resected. The trachea was then separated from the oesophagus and 4cm of trachea was resected en bloc immediately below the cricoid cartilage. Both cricothyroid joints were preserved. Frozen sections were taken and margins were deemed histologically clear. Microscopically there were nests and cords of moderately sized epitheloid cells with prominent nucleoli, with focal glands and tubules. Lymphovascular and perineural invasion was present. Keratinization was not present. CK14 and epithelial membrane antigen (EMA) immunostaining was focally positive. CK7 was mainly positive. Thyroglobulin, thyroid transcription factor 1 (TTF1), carcinoembryonic antigen (CEA), and calcitonin were negative.
Our patient was discharged 9 days after the procedure. Calcitriol and Calcium were prescribed to control hypocalcemia. Two months after the procedure she was admitted for dyspnoea and stridor. Microlaryngoscopy revealed polypoid granulation tissue in the anterior upper trachea. A biopsy of this tissue revealed tumour recurrence. She commenced radiotherapy shortly thereafter. A CT performed 7 months after her diagnosis revealed disease progression with 8 nodules in the lungs consistent with metastasis. She died days later at home of haemorrhage into her airway. 
DISCUSSION
This is the first case of SMECE of the thyroid reported in New Zealand. The course of our patient's disease was aggressive and involved distant metastases. Up until recently, SMECE of the thyroid has been considered a low grade malignancy and distant metastases were thought to be uncommon, with some exceptions. [4] [5] [6] Previous case reports have shown largely good outcomes for patients. 7 However a recent study by Quiroga-Garza G et al suggests that SMECE of thyroid is more aggressive than previously thought. 3 They found distant metastases in 50% of their patients with SMECE of the thyroid. Further, a literature review in 2004 by Shehadeh et al found 4 out of 23 patients with SMECE of thyroid also had distant metastatic disease. 2 Our experience, and that of previously aforementioned published cases, raise concern that SMECE may not follow the natural history of a low grade malignancy. In the literature patients are often reported to survive many years after their diagnosis. Our patient deteriorated rapidly and died 7 months from initial diagnosis.
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